BETNOVATE crème tb 30 g

7680309680269 CH-30968 D07AC01 10.05.1.
BETNOVATE crème tb 30 g
BETNOVATE crème tb 30 g
BETNOVATE crème tb 30 g
1 / 3
google

Details

Product number
3096801
CPT
-
Packaging group
30
Unit
g
Composition
betamethasonum 1 mg ut betamethasoni valeras, macrogoli aether cetostearylicus, alcohol cetylicus et stearylicus 72 mg, vaselinum album, paraffinum liquidum, natrii dihydrogenophosphas dihydricus, acidum phosphoricum aut natrii hydroxidum, chlorocresolum 1 mg, aqua purificata, ad unguentum pro 1 g.

Articles (1)

Betnovate, Crème
Crème
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
72.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 12.75
Specialties list
Yes
Generic
No
SL addition date: 15/03/1965

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
30968
Drug name
Betnovate, Crème
Galenic form
CREM
ATC Code
D07AC01
Authorization status
Z
Dispensation category
B
First authorization
16/10/1964
Authorization expiration date
31/12/9999
IT number
10.05.1.
Domain
Human medicine
Field of application
Entzündliche, nicht infizierte Dermatosen

Packaging details

Description (FR)
BETNOVATE crème tb 30 g
Description (DE)
BETNOVATE Creme Tb 30 g
Market launch
16/10/1964
Narcotic (BTM)
No

Other packaging sizes